Thorne's New Scientific Advisory Board
Thorne, a leading name in science-based health and wellness solutions, has announced a significant step forward in its commitment to innovation and quality by establishing a Scientific Advisory Board (SAB). This board aims to enhance practitioner support and fortify connections within the health and wellness industries. Comprising of distinguished professionals from various health disciplines—including longevity, human performance, and women's health—the SAB is set to play a pivotal role in driving innovation at Thorne.
Meet the Board Members
The SAB will be led by Thorne's Chief Scientific Officer,
Dr. Nathan Price, PhD, who expressed enthusiasm about the caliber of experts involved. The board's members include:
- - Dr. Laura D. Baker, PhD: A leading cognitive neuroscientist at Wake Forest University, specializing in cognitive aging and interventions to protect brain health.
- - Dr. Brent Bauer, MD: Director of Research at Mayo Clinic's Integrative Medicine Program, known for his efforts in ensuring high standards in research quality.
- - Dr. Sean Gibbons, PhD: Associated with the Institute for Systems Biology, his research focuses on microbial ecosystems and their impacts on host health.
- - Dr. Vadim Gladyshev, PhD: A Harvard Medical School professor renowned for his work on aging and lifespan, having published over 450 articles on these subjects.
- - Dr. Jacqueline Jacques, ND: With extensive experience in the wellness space, she has held leadership roles and is also a noted author in the industry.
- - Dr. Mahtab Jafari, PharmD: Director of Healthspan Services at UC Irvine, her research includes the impact of wellness interventions on mental and physical health.
- - Dr. Robert Rountree, MD: A physician with over three decades in integrative medicine who focuses on personalized healthcare consulting.
- - Dr. Sara Szal, MD: Director of the Precision Medicine Program at Jefferson Health, known for her work in integrating technology and health.
A Commitment to Innovation
Dr. Price highlighted the board as a robust group of leaders who have made substantial contributions to science and health innovation. He stated, "Their combined expertise, innovative thinking, and proven track record will be invaluable to Thorne as we advance our commitment to scientific rigor, innovation, and personal performance in evidence-based wellness optimization."
The SAB will collaborate closely with Thorne's leadership team to bolster research and development initiatives tailored toward personalized health solutions. A shared vision of advancing human health will underpin the board's efforts, particularly focusing on the intersection of science and wellness.
Thorne's Legacy and Future
Founded in 1984, Thorne prides itself on being the most recommended clinical brand by healthcare practitioners, offering a wide range of nutritional supplements and health tests tailored to meet individual needs. Thorne has always prioritized assembling high-quality products formulated with evidence-based research, ensuring that they meet the rigorous standards of purity, potency, and efficacy.
With its robust commitment to quality, Thorne has earned the trust of over 47,000 health care professionals and numerous professional athletes, including members of more than 100 professional sports teams.
As it embraces new frontiers of wellness through the advisory board, Thorne is poised to deepen its impact on human health, bridging the gap between scientific research and practical wellness solutions.
For more information on Thorne's products and initiatives, visit
Thorne.com.